Pyrexar Medical In The News

Thermal Therapy reaches South Korea’s Cancer Patients

Seoul, Korea – Pyrexar Medical, leaders in thermal therapy systems for cancer treatment, announced the delivery of two new BSD-2000 Deep Regional Hyperthermia systems to prominent hospitals in South Korea.  Pyrexar’s  Field Service Manager, Ray Lauritzen, was joined by local distributor HanBeam Technology, for the onsite installation and training.  Recipients of the first BSD-2000 systems in Korea are the newly opened Healer’s Care Hospital in the city of Busan and the YCH Cancer Hospital in Seoul. Both oncology groups were looking forward to treating patients with the new systems.

South Korea has the eighth highest cancer rate in the world, just below the United States. Tracking cancer statistics in the country is the KCCR (Korea Central Cancer Registry), a nationwide hospital-based cancer registry established by the Ministry of Health and Welfare. According to the KCCR, stomach and colorectal cancer are some of the highest incidence of cancer among men and women in the country.

Hyperthermia, also known as thermal therapy, is clinically proven to boost the effectiveness of radiation therapy and chemotherapy in cancer patients. Thermal therapy works by increasing blood flow and oxygenation to the tumor site.  As an adjunct therapy to radiation treatment, hyperthermia increases the number of oxygen radicals that can be produced to destroy cancer cells.  When used with chemotherapy, thermal therapy treatments sensitize the tumor site allowing more cancer killing agents to target the tumor.

“We are certain this technology is the beginning of improved clinical outcomes in the region and we will continue to expand our market reach by working with channel partners throughout the world.” said Mark Falkowski, CEO. “Pyrexar continues to deliver the best advanced technological in the thermal therapy marketplace.”

Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR HyperThermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissues.

To find out more about Pyrexar Medical products, visit our webpage  For information about purchasing our products in South Korea, contact